GLAUKOS Corp - 8-K Filing

Glaukos released an investor presentation outlining its growth strategy, pipeline advancements, and market position in interventional therapies for keratoconus and glaucoma. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $GKOS

Read the full article at SEC EDGAR

More Regulatory news